Author： Borges Nuno
Publisher： Informa Healthcare
ISSN： 1474-0338
Source： Expert Opinion on Drug Safety, Vol.4, Iss.1, 2005-01, pp. : 69-73
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Tolcapone-Related Liver Dysfunction: Implications for Use in Parkinson's Disease Therapy
By Borges N.
Drug Safety, Vol. 26, Iss. 11, 2003-01 ,pp. :
Access to resources
Recommend
Implementing NICE clinical guidelines on Parkinson’s disease
By Ryton Beverly A Liddle B Jane
Clinical Medicine, Vol. 9, Iss. 5, 2009-10 ,pp. :
Clinical Pharmacology, Therapeutic Use and Potential of COMT Inhibitors in Parkinsons Disease
By Kaakkola S.
Drugs, Vol. 59, Iss. 6, 2000-06 ,pp. :